FimmCyte
PrivateLast Round
Convertible Debt
Feb 29, 2024
Total Funding Raised
$2.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FimmCyte is a biotechnology company developing targeted immunotherapies for chronic fibro-inflammatory diseases with an initial focus on endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FimmCyte Comparables
Compare FimmCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oriva Therapeutics | 86% | |
| EndoCyclic Therapeutics | 84% | |
| Sur180 Therapeutics | 83% | |
FimmCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Feb 29, 2024 | ||||
| Convertible Debt | Sep 5, 2023 | ||||
| Grant | Jul 13, 2022 |
FimmCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Kick | Grant |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased from 0 to 2, representing 29% of headcount.
- Mar 25, 2025
Monthly visitors grew 254% MoM, reaching 1.4K.
FimmCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FimmCyte's valuation, stock price, and market status.